Clinical Trial Update: Safety and Immunogenicity of HIL-214 in Healthy Japanese Infants [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety and immunogenicity of HIL-214 in healthy Japanese infants has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• HIL-214

Snippet

Sponsor: HilleVax | Conditions: Gastroenteritis | Phase 1 | Status: COMPLETED | Results posted: 2025-03-14